BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38145078)

  • 1. Carbapenem resistant
    Thomsen J; Abdulrazzaq NM; ; Everett DB; Menezes GA; Senok A; Ayoub Moubareck C
    Front Public Health; 2023; 11():1244482. PubMed ID: 38145078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and antimicrobial resistance trends of
    Thomsen J; Abdulrazzaq NM; AlRand H; ; Everett DB; Senok A; Menezes GA; Ayoub Moubareck C
    Front Public Health; 2023; 11():1245131. PubMed ID: 38239785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving trends among
    Thomsen J; Menezes GA; Abdulrazzaq NM; ; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1243973. PubMed ID: 38106909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and genotypic characteristics of carbapenem resistant Enterobacterales in Henan, China: a multicentre study.
    Jing N; Yan W; Zhang Q; Yuan Y; Wei X; Zhao W; Guo S; Guo L; Gao Y; Zhao L; Shi C; Li Y
    J Glob Antimicrob Resist; 2022 Jun; 29():68-73. PubMed ID: 35134552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical epidemiology of carbapenem resistant
    Baleivanualala SC; Matanitobua S; Soqo V; Smita S; Limaono J; Sharma SC; Devi SV; Boseiwaqa LV; Vera N; Kumar S; Lalibuli A; Mailulu J; Wilson D; Samisoni Y; Crump JA; Ussher JE
    Lancet Reg Health West Pac; 2024 Jun; 47():101095. PubMed ID: 38867891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017-2020.
    Karlowsky JA; Lob SH; Khan TK; Chen WT; Woo PCY; Seto WH; Ip M; Leung SWM; Wong QW; Chau RWY; DeRyke CA; Young K; Motyl MR; Sahm DF
    J Glob Antimicrob Resist; 2023 Jun; 33():260-266. PubMed ID: 37086892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.
    Lee MC; Chang H; Sun FJ; Wu AY; Lu CH; Lee CM
    Am J Trop Med Hyg; 2022 Aug; 107(2):467-473. PubMed ID: 35895586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and genotypic detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Accra, Ghana.
    Dwomoh FP; Kotey FCN; Dayie NTKD; Osei MM; Amoa-Owusu F; Bannah V; Alzahrani FM; Halawani IF; Alzahrani KJ; Egyir B; Donkor ES
    PLoS One; 2022; 17(12):e0279715. PubMed ID: 36584159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance.
    Ikenoue C; Matsui M; Inamine Y; Yoneoka D; Sugai M; Suzuki S;
    BMC Infect Dis; 2024 Feb; 24(1):209. PubMed ID: 38360618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Effects of Antibiotics on
    Chen J; Xiang Q; Wu JY; Huang XB; Wang C; Wei DQ; Lv Y
    Microb Drug Resist; 2022 Jun; 28(6):660-669. PubMed ID: 35639423
    [No Abstract]   [Full Text] [Related]  

  • 13. A critical role of outer membrane vesicles in antibiotic resistance in carbapenem-resistant Klebsiella pneumoniae.
    Yao L; Wei B; Wang Y; Xu B; Yang M; Chen X; Chen F
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):95. PubMed ID: 37919721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characteristics of ertapenem-mono-resistant isolates among carbapenem-resistant Enterobacterales in China.
    Wang Y; Hu H; Shi Q; Zhang P; Zhao D; Jiang Y; Yu Y
    Emerg Microbes Infect; 2024 Dec; 13(1):2332658. PubMed ID: 38517707
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Goel A; Gupta V; Singhal L; Palta S; Chander J
    Indian J Med Res; 2021 Mar; 154(3):520-526. PubMed ID: 35345078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
    Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS
    Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological Characteristics of OXA-232-Producing Carbapenem-Resistant Klebsiella pneumoniae Strains Isolated during Nosocomial Clonal Spread Associated with Environmental Colonization.
    Han X; Chen Y; Zhou J; Shi Q; Jiang Y; Wu X; Quan J; Hu H; Wang Q; Yu Y; Fu Y
    Microbiol Spectr; 2022 Aug; 10(4):e0257221. PubMed ID: 35730968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
    Paveenkittiporn W; Lyman M; Biedron C; Chea N; Bunthi C; Kolwaite A; Janejai N
    Antimicrob Resist Infect Control; 2021 Jun; 10(1):88. PubMed ID: 34090537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.